Parenteral Versus Oral Iron Therapy in Postpartum Anemia
Abstract
Objective: To compare the efficacy of oral ferrous sulphate and intravenous ferrous sucrose in postpartum iron deficiency anemia.
Study Design: Randomized control experimental study.
Place and Duration of Study: This study was conducted at the Postoperative and postnatal wards of sheikh Zaid women hospital Larkana from 1ST April 2016 to 30 September 2016.
Materials and Methods: Sixty cases of postpartum iron deficiency anemia were collected for this study and they were divided in two groups of 30 each. Group A was treated by intravenous ferrous sucrose 200mg given on day 2 and 4 of delivery (two doses only). Group B patients were received oral ferrous sulphate 200mg daily for 6 weeks. The follow up was done at day 15 and 40 postpartum in each group in term of increase hemoglobin and
ferritin level.
Results: The mean Hb within 24-48 hours of delivery was 8.14±0.48gm/dl in group A and 8.73±0.66gm/dl in group B. The mean serum ferritin level was 11.37±1.67mcg/L in group A and 12.43±1.48mcg/L in group B. In group A, the mean Hb after 15 days follow up was 11.29±1.32gm/dl and in group B 9.94±0.55gm/dl and in group A, the mean serum ferritin level was 34.69±3.27mcg/L and in group B 14.73±0.98mcg/L. In group A, the mean Hb after 40 days follow up was 12.89±0.79 gm/dl and in group B was 11.40±0.39 gm/dl and in group A, the mean serum ferritin level was 46.18±4.05 mcg/L and in group B was 17.47±1.30 mcg/L.
Conclusion: Intravenous iron sucrose therapy increases the Hb level as well as serum ferritin level more rapidly than oral ferrous sulphate in women with postpartum anemia deficiency anemia.




























This work is licensed under a